Why Neola Medical stock moves
Neola Medical fell clearly, more than the market.
Written after the close on ·
Why today
16,415 news analyzed todayNeola Medical fell clearly, more than the market.
The market, OMX Stockholm 30, fell slightly over the same day.
No company news explains the drop in the last session.
Over the last five trading days the stock fell sharply while the market rose slightly.
Earlier news, an FDA Breakthrough Device Designation on 4 September, is background only.
Today's move of −3.20% was 1.3 times a normal day's 2.5%. OMX Stockholm 30 moved −0.32% on the same day.
Neola Medical −3.20%OMX Stockholm 30 −0.32%Much weaker than the market
What analysts expect, and how often they have been right
Analysts’ estimates for Neola Medical.
Price targets
Latest price 0.48 SEK
People on the board and in management must report their trades in the share to Finansinspektionen, Sweden's financial supervisor. No reported trades in the past year.
Has the share price followed the business?
Price and earnings moved in the same direction: 2 out of 3 years. Across Nordic companies, that happens in about 60% of years. In 2025, the price changed −48% and earnings per share went from -0.14 SEK to -0.14 SEK.
Revenue, profit and market cap
RevenueProfitMarket capHatched bars: analysts’ estimates.m SEK
Assets, liabilities and market cap
AssetsLiabilitiesMarket capm SEK
Price and earnings moved in the same direction: 2 out of 3 years.Market cap (Now): 53.2 m SEKRevenue 2025: 0.0 m SEK
What the key figures say about Neola Medical
The figures connect what Neola Medical earns with what investors pay.
The line shows the share price in the same year, on its own scale. Hatched bars: analysts’ estimates.
Profit divided by the number of shares. Each share represents this much of the earnings.
2022–2025: -0.39 SEK–-0.14 SEK. Peers: Qlife Holding -1.27 SEK, Nosa Plugs -0.03 SEK, Bactiguard Holding 0.22 SEK.
What the company sold during the year.
2022–2025: 0.0 m SEK–0.0 m SEK. Peers: Qlife Holding 0.9 m SEK, Nosa Plugs 31.8 m SEK, Bactiguard Holding 217 m SEK. 2026 estimate: 12.1 m SEK (12.1 m SEK–12.1 m SEK). 2027 estimate: 13.3 m SEK (13.3 m SEK–13.3 m SEK).
Profit as a percentage of shareholders’ money in the company.
2022–2025: −15.3%–−11.4%. Peers: Nosa Plugs −18.6%, Bactiguard Holding 2.0%.
More key figures
Market cap divided by shareholders’ equity, what remains after liabilities.
2022–2025: 1.13–2.13. Peers: Qlife Holding 10.29, Nosa Plugs 2.69, Bactiguard Holding 1.73.
Cash left after investments, divided by the number of shares.
2022–2025: -0.35 SEK–-0.26 SEK. Peers: Qlife Holding -0.63 SEK, Nosa Plugs -0.02 SEK, Bactiguard Holding 0.79 SEK.
The percentage of assets financed by shareholders’ equity.
2022–2025: 89.6%–96.2%.
What followed similar falls?
Including reinvested dividends, Neola Medical fell 12.0% over the latest five trading days. Since October 2, 2020, falls at least this large were followed by a higher value 21 trading days later in 15 out of 29 non-overlapping periods. The median was +0.9%, against −3.5% for an ordinary 21-day period, which ended higher 39 times in 100.
Such a fall has not said much about the next month.
+0.9% · 15/29
More about Neola Medical
Insider trades
People on the board and in management must report their trades in the share to Finansinspektionen, Sweden's financial supervisor.
No reported trades in the past year.
Earnings report
On its last 16 report days Neola Medical usually moved about 3.2%. On a normal day it moves 2.5%.
−9.01% +0.93% +6.27% −12.46%
10,000 SEK in Neola Medical bought on October 2, 2020 is worth 872 SEK today, with dividends reinvested.
The same amount in OMX Stockholm 30 with dividends would have become 21,500 SEK.
What would 10,000 SEK in Neola Medical be worth today? →
What would 10,000 SEK in Neola Medical be worth today?
872 SEK
with dividends reinvested, bought on October 2, 2020. The same amount in OMX Stockholm 30 with dividends would have become 21,500 SEK.
At worst it was worth 818 SEK (October 9, 2026).
The five biggest days of the journey
· +97.4% · the whole market fell 0.6% the same day
· −35.9% · the whole market rose 0.5% the same day
· +30.1% · the whole market rose 0.9% the same day
· +26.9% · the whole market rose 0.2% the same day
· +25.8% · the whole market fell 0.5% the same day
Earlier days
−6.41% market −0.11% Neola Medical fell clearly over the last five trading days, while the broader market was roughly flat. Read →
Neola Medical fell clearly over the last five trading days, while the broader market was roughly flat.
Neola Medical has had no company news in the past two weeks.
The share price moved mostly with the sector, where other Healthcare stocks on Nasdaq First North Sweden also slipped slightly.
Trading was thin, so the move may partly reflect fewer buyers than usual.
−3.85% market +0.83% Neola Medical fell clearly without company news. Read →
Neola Medical fell clearly without company news.
The share fell clearly against a rising market over the last five trading days, with heavy trading about three times a normal session.
The latest close sits well below its high from late April but above its low from early October.
Earlier company news includes FDA Breakthrough Device Designation for Neola, announced on 4 September, which is background only.
+5.69% market −0.08% Neola Medical rose sharply, without company news. Read →
Neola Medical rose sharply, without company news.
OMX Stockholm 30 was roughly flat over the same days, so Neola Medical moved apart from the market.
Trading was about three times a normal session.
Over the last five trading days Neola Medical fell slightly, while the market rose slightly.
The move is not explained by company news in this period.
−4.47% market +0.48% Neola Medical fell, moving against a market that rose slightly. Read →
Neola Medical fell, moving against a market that rose slightly.
No company news explains the drop.
Over the last five trading days it fell clearly while OMX Stockholm 30 rose clearly.
Trading was about twice its usual level, so heavy selling likely drove the move.
The sector also fell over the same days, so sector mood may have played a part.
−6.36% market −0.29% Neola Medical fell sharply without a company-news explanation. Read →
Neola Medical fell sharply without a company-news explanation.
The market fell slightly over the same day, so Neola Medical fell much more than the stock market.
Over the last five trading days the shares were roughly unchanged, while OMX Stockholm 30 rose clearly.
Trading volume was around its usual level, and the shares sit well below their high of the past year.
−0.96% market +3.01% Neola Medical was roughly unchanged over the week. Read →
Neola Medical was roughly unchanged over the week.
The OMX Stockholm 30 index rose clearly over the same days, so the company moved less than the market.
The sharp fall in the last session pushed the shares down more than the index, which fell only slightly.
The only company news in the window is an estimates update, which does not clearly explain the move.
−6.48% market +0.41% Neola Medical fell sharply, against a rising market. Read →
Neola Medical fell sharply, against a rising market.
Over the last five trading days the shares fell slightly, while OMX Stockholm 30 rose sharply, so the stock lagged the market.
Trading was very heavy in the last session, about eight times a normal day.
No company news explains the sharp drop in that session.
The only item in the news is an analyst estimates update from before that session, so it cannot be the cause of the move.
+0.93% market +0.33% Neola Medical rose slightly, without company news. Read →
Neola Medical rose slightly, without company news.
Over the same day, OMX Stockholm 30 also rose slightly, so the stock moved about in line with the market.
Over the last five trading days, Neola Medical rose clearly, outpacing OMX Stockholm 30, which rose slightly.
Trading was well above its usual level, about 22 times a normal session, so heavy buying or selling likely took place even though the price barely moved.
Sector peers fell over the week, so the stock's rise ran against the wider Healthcare group.
+6.56% market −3.67% Neola Medical rose clearly over the last five trading days, moving against a sharply falling OMX Stockholm 30. Read →
Neola Medical rose clearly over the last five trading days, moving against a sharply falling OMX Stockholm 30.
Neola Medical has had no company news in this period, so no single event explains the rise.
Trading was well below its usual level, so the move happened on thin activity.
+5.00% market −2.51% Neola Medical rose sharply without company news explaining it. Read →
Neola Medical rose sharply without company news explaining it.
While it rose, OMX Stockholm 30 fell sharply, so the stock moved against the market.
Over the last five trading days, Neola Medical rose sharply, against a clear market fall.
This was a big move, about twice a normal five-day stretch, and similar moves happened about 12 times in the past year.
Trading volume was around its usual level.
+4.27% market +1.25% Neola Medical rose clearly without company news. Read →
Neola Medical rose clearly without company news.
Neola Medical rose clearly over the last five trading days, moving more than the broader OMX Stockholm 30 index, which rose only slightly over the same stretch.
There has been no company news about Neola Medical in the past two weeks, so the move is most likely driven by sector sentiment in healthcare and by general investor appetite for smaller, faster-moving shares rather than by any specific announcement.
The same market rose clearly in the last session, so part of the gain likely reflects a broad risk-on mood that lifted the index as well.
+7.49% market +1.19% Neola Medical rose clearly over the last five trading days, a stronger move than the broader market, which edged up slightly over the same stretch. Read →
Neola Medical rose clearly over the last five trading days, a stronger move than the broader market, which edged up slightly over the same stretch.
There has been no company news about Neola Medical in this period, so the move most likely reflects general investor interest in healthcare shares, with the company's stock responding more strongly than the wider index, which is typical for smaller medical names that can react sharply to shifts in sentiment.
Investors may next look at the broader healthcare sector's direction and at the market's largest daily moves within this window.
−2.50% market −0.02% Neola Medical fell clearly without company news, while the broader Stockholm market was roughly flat. Read →
Neola Medical fell clearly without company news, while the broader Stockholm market was roughly flat.
Over the last five trading days the stock was roughly unchanged and lagged a slightly rising OMX Stockholm 30.
With no company news in the period, the drop most likely reflects selling pressure within the healthcare sector and general investor repositioning rather than a specific company event.
Healthcare stocks often react to sector sentiment and shifts in expectations, which can move a single name even when the index is steady.
+5.73% market +0.21% Neola Medical rose sharply without company news. Read →
Neola Medical rose sharply without company news.
Neola Medical has had no company news in the past five trading days, so the move was not tied to any announcement from the company.
Over the last five trading days the stock rose slightly, meaning the bulk of the gain came in the most recent session rather than building steadily through the week, while the OMX Stockholm 30 — the Stockholm exchange's index of its thirty most traded companies — was roughly unchanged.
A small healthcare company like this, with a narrow shareholder base and thin trading, can swing hard on modest buying interest or a single larger order, and a quiet, flat market gives that kind of move nothing to push against.
What to watch next is whether the company's next report gives the move any substance, since nothing in the news flow does.
Learn more · Why do stocks go up and down?